Pay in 4 interest-free payments of $6.98 Learn more
Ships within 48 hours · Estimated delivery Sep 14 - Sep 19
OASIS trials: establishing effective doses Phase 2 OASIS 1 findings: Tested multiple dose levels: 0.3mg, 0.6mg, 1.2mg, 2.4mg, 4.5mg weekly Duration: 26 weeks Primary endpoint: Weight loss at each dose Dose-response results: 0.3mg weekly: ~4% body weight loss 0.6mg weekly: ~6% body weight loss 1.2mg weekly: ~8% body weight loss 2.4mg weekly: ~10% body weight loss 4.5mg weekly: ~12% body weight loss Key insight: Clear dose-response relationship
after five years, medical review still applies when recurrence risk or active surveillance remains relevant
The nose offers a large surface area
Key Highlights
This type of procedure restores hydration to the lips, readily creating renewed plumpness and diminishing the appearance of wrinkles and creases
In the Ehrlich ascites carcinoma mouse model, BV has been found to lower MMP-2 and MMP-9, as well as VEGF, TNF-, and nitric oxide (NO) levels, hence decreasing tumor growth and preventing angiogenesis (El Bakary et al., 2020)
US$ 25.81
US$ 20.43
US$ 25.39
US$ 21.60
US$ 20.89
US$ 28.00
US$ 20.90
US$ 29.03
US$ 26.39
US$ 26.81